A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer

NY Cancer and Blood Specialists, The Bronx

Alexandria Hospital, Department of Oncology, Athens

North Shore Hematology Oncology Associates, East Setauket

Associated Medical Professionals of NY, Syracuse

Urologic Consultants of Southeastern Pennsylvania, Bala-Cynwyd

Virginia Oncology Associates, Norfolk

Duke Cancer Institute at Cary: Medical Oncology, Cary

Duke University Medical Center, Durham

Charleston Hematology Oncology Associates, Charleston

Carolina Urologic Research Center, Myrtle Beach

H. Lee Moffitt Cancer and Research Institute, Tampa

Urology Centers of Alabama, Homewood

Gabrail Cancer Center Research, Canton

First Urology, PSC, Jeffersonville

University of Wisconsin Carbone Cancer Center, Madison

Wichita Urology, Wichita

Urology Cancer Center, Omaha

Urology Clinics of North Texas, Dallas

University of Texas MD Anderson Cancer Center, Houston

Comprehensive Cancer Centers of Nevada, Las Vegas

Kantonsspital St Gallen, Onkologie/ Hamatologie, Sankt Gallen

The Royal Marsden Hospital - Institute of Cancer Research, Sutton

Guys and St. Thomas' NHS Foundation Trust, London